glp-1 fda approval 💊New pill gets approval, and has fewer restrictions on how it's used💊 Live Updates on Semaglutide's Current

Important safety considerations include: Cardiovascular history : Patients with established cardiovascular disease require careful assessment, though recent evidence suggests GLP-1 receptor agonists may offer cardiovascular benefits Medication interactions : No clinically significant interactions are expected between GLP-1 receptor agonists and statins or other lipid-lowering medications, though delayed gastric emptying could theoretically affect absorption of oral medications Pancreatitis risk : Whilst rare, acute pancreatitis has been reported with GLP-1 receptor agonists

Bhagavathula, A.S

Patients notice that they feel less hungry, they get full faster, and they often lose weight

While Dihexa is generally considered safe, certain individuals may need to exercise extra caution or avoid it altogether